Qiagen holds the cleaner structural position, with the lead spread across profitability and stability. Pfizer still has the edge on valuation, which keeps the comparison from looking entirely one-sided. In the market, Pfizer carries the stronger setup — intact trend against Qiagen's broken trend. That leaves a split case: the structural lead stays with Qiagen, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels.
This is not just a one-metric split: both profitability and stability materially support the lead. Qiagen N.V. leads by 20 points on the overall comparison score.
This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.
A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.
The clearest structural overlap shows up in margin trend and recent revenue growth.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
Qiagen N.V. occupies the cheaper side of the setup map, although Pfizer Inc. still holds the stronger structural profile.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
The profitability gap is very wide, with the stronger side earning materially better operating marks.
Absolute pricing still looks more supportive for Pfizer, with a forward P/E that is 5.5 turns lower there.
The lead is built on both profitability and stability — though valuation still provides a counterweight.
Break down the PFE vs QIA.DE comparison across all dimensions with the full interactive tool.
Explore how PFE and QIA.DE each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.